Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation

1 year ago 59

Allschwil, Switzerland, June 20, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting...

Read Entire Article

Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation

Related

Running success for man who relearnt how to walk after child...

Turning heartbreak into a legacy of helping

Mila beat cancer, but not the bullies. How a Virginia wig st...

Trending

Popular

Darwin woman forced to fly interstate for a cancer diagnosis...

Reduce your risk of cancer: get involved and have fun

Stone Roses legend’s wife dead aged 52 after long cancer bat...

B.C. woman raises awareness of pancreatic cancer after husba...

Former OU 2-sport standout Ryan Minor has no more treatment ...